OBX Obsidian Therapeutics, Inc.
Fundamentals / CIK 0002130606 / USDObsidian Therapeutics, Inc. reported $340.7M in total assets through September 30, 2026 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OBX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2026-- Sep 30, 2026
-
Operating Income FY 2026-- Operating profit
-
Net Income FY 2026-- GAAP bottom line
-
Diluted EPS FY 2026-- Split-adjusted
-
Free Cash Flow FY 2026-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$214.9M Total debt: $4.05M
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Revenue | $0 | -- | -- | $0 | -- | -- |
| Research & Development | $27.55M | -- | -- | $25.05M | -- | -- |
| Total Operating Expenses | $52.91M | -- | -- | $29.63M | -- | -- |
| Operating Income | -$52.91M | -- | -- | -$29.63M | -- | -- |
| Income Before Tax | -$50.66M | -- | -- | -$28.47M | -- | -- |
| Income Tax Expense | $0 | -- | -- | $0 | -- | -- |
| Net Income | -$50.66M | -$25.86M | -$19.63M | -$28.47M | -$26.90M | -$24.99M |
| Basic EPS | -$1.23 | -- | -- | -$14.77 | -- | -- |
| Diluted EPS | -$1.23 | -- | -- | -$14.77 | -- | -- |
| Basic Shares Outstanding | 41.0M | -- | -- | 1.9M | -- | -- |
| Diluted Shares Outstanding | 41.0M | -- | -- | 1.9M | -- | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2025-12-31 |
|---|---|---|---|
| Cash & Cash Equivalents | $66.51M | -- | $40.41M |
| Short-Term Investments | $148.4M | -- | $40.08M |
| Cash & Short-Term Investments | $324.4M | -- | $80.50M |
| Total Current Assets | $224.5M | $0 | $81.52M |
| Property, Plant & Equipment, Net | $961K | -- | $1.91M |
| Long-Term Investments | $109.4M | -- | $0 |
| Other Non-Current Assets | -- | $0 | -- |
| Total Non-Current Assets | $116.2M | $0 | $7.06M |
| Total Assets | $340.7M | $0 | $88.58M |
| Accounts Payable | $569K | -- | $12K |
| Other Current Liabilities | $1.59M | -- | $1.42M |
| Total Current Liabilities | $18.26M | $0 | $15.36M |
| Other Non-Current Liabilities | $0 | $0 | $3.0K |
| Total Non-Current Liabilities | $1.90M | $299.7M | $1.23M |
| Total Liabilities | $20.16M | $299.7M | $16.59M |
| Total Debt (incl. Leases) | $4.05M | -- | $4.28M |
| Common Stock | $6.0K | $0 | $1.0K |
| Retained Earnings | -$392.1M | $0 | -$295.9M |
| Accumulated Other Comp. Income | -$1.20M | $0 | $23K |
| Total Stockholders' Equity | $320.6M | -$299.7M | -$266.0M |
| Total Equity | $320.6M | -$299.7M | -$266.0M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Net Income | $50.66M | -$25.86M | -$19.63M | $28.47M | -$26.90M | -$24.99M |
| Stock-Based Compensation | $2.26M | -- | -- | $2.23M | -- | -- |
| Change in Working Capital | -- | $0 | -- | -- | -- | -- |
| Operating Cash Flow | -- | $0 | -- | -- | -- | -- |
| Investing Cash Flow | -- | $0 | -- | -- | -- | -- |
| Financing Cash Flow | -- | $0 | -- | -- | -- | -- |
| Net Change in Cash | -- | $0 | -- | -- | -- | -- |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Current Ratio | 12.29x | -- | -- | -- | -- | -- |
| Quick Ratio | 17.76x | -- | -- | -- | -- | -- |
| Debt to Equity | 0.01x | -- | -- | -- | -- | -- |